Cross-fund · 3 holders
LGND
LIGAND PHARMACEUTICALS INC
CUSIP 53220K504
3
Tracked holders
$987.5M
Aggregate value
5,055,811
Shares
4
Active funds
Funds holding LGND
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| BlackRock | Institutional | Q1 2026 | $591.3M | 0.01% | +21,692 | +0.7% |
| Vanguard | Institutional | Q4 2025 | $392.1M | 0.01% | -2,391 | -0.1% |
| Citadel | Multi-Strategy | Q1 2026 | $4.0M | — | +7,030 | +54.2% |
| BridgewaterFEAT | Macro | Q1 2026 | — | — | -4,207 | EXITED |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.